See more : Afarak Group Oyj (AFAGR.HE) Income Statement Analysis – Financial Results
Complete financial analysis of TILT Holdings Inc. (TLLTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TILT Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Fertoz Limited (FTZ.AX) Income Statement Analysis – Financial Results
- Souyute Group Co.,Ltd (002503.SZ) Income Statement Analysis – Financial Results
- Academy Sports and Outdoors, Inc. (ASO) Income Statement Analysis – Financial Results
- Road King Infrastructure Limited (1098.HK) Income Statement Analysis – Financial Results
- Orla Mining Ltd. (ORLA) Income Statement Analysis – Financial Results
TILT Holdings Inc. (TLLTF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.tiltholdings.com
About TILT Holdings Inc.
TILT Holdings Inc. operates in the cannabis industry in the United States, Canada, Israel, Mexico, South America, and the European Union. It operates through Cannabis, Accessories, and Other segments. The company engages in the production, cultivation, extraction, and sale of cannabis products; manufacture and distribution of electronic and non-nicotine devices and systems; and focuses on greenhouse cultivation and CO2 extraction. It also processes and provides medical cannabis products, including flower, infused products, concentrates, topicals, tinctures, vape cartridges, and syringes. The company is headquartered in Phoenix, Arizona.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 165.96M | 174.19M | 202.71M | 158.41M | 152.94M | 5.66M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 154.34K | 1.55M | 1.99M | 1.74M | 0.00 | 0.00 |
Cost of Revenue | 147.18M | 136.02M | 144.50M | 99.45M | 97.80M | 3.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 31.55K | 271.83K | 280.14K | 188.04K | 0.00 | 0.00 |
Gross Profit | 18.77M | 38.17M | 58.21M | 58.96M | 55.14M | 2.45M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 122.79K | 1.27M | 1.71M | 1.55M | 0.00 | 0.00 |
Gross Profit Ratio | 11.31% | 21.91% | 28.71% | 37.22% | 36.05% | 43.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 79.56% | 82.41% | 85.90% | 89.19% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 106.00K | 62.12K | 98.23K | 16.15K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.97K | 334.44K | 552.49K | 505.95K | 0.00 | 0.00 |
General & Administrative | 19.46M | 46.09M | 37.52M | 40.21M | 129.89M | 51.89M | 46.28K | 43.42K | 55.82K | 84.04K | 100.08K | 141.59K | 448.27K | 816.31K | 1.20M | 1.39M | 0.00 | 0.00 |
Selling & Marketing | 1.16M | 2.45M | 2.16M | 611.00K | 2.20M | 718.02K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 44.79K | 416.69K | 747.45K | 1.50M | 0.00 | 0.00 |
SG&A | 20.62M | 48.54M | 39.68M | 40.82M | 132.09M | 51.89M | 46.28K | 43.42K | 55.82K | 84.04K | 100.08K | 141.59K | 493.06K | 1.23M | 1.95M | 2.89M | 59.01K | 4.54K |
Other Expenses | 41.31M | 18.35M | 18.46M | 18.52M | 24.72M | 648.87K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 980.42K | -40.32K | -140.33K | -187.45K | 0.00 | 0.00 |
Operating Expenses | 61.93M | 66.89M | 58.25M | 59.34M | 156.81M | 52.54M | 46.28K | 43.42K | 55.82K | 84.04K | 100.08K | 141.59K | 505.03K | 1.53M | 2.36M | 3.21M | 59.01K | 4.54K |
Cost & Expenses | 209.11M | 202.91M | 202.75M | 158.79M | 254.61M | 55.75M | 46.28K | 43.42K | 55.82K | 84.04K | 100.08K | 141.59K | 536.58K | 1.80M | 2.64M | 3.40M | 59.01K | 4.54K |
Interest Income | 0.00 | 215.00K | 592.00K | 3.84M | 3.28M | 44.12K | 33.41 | 190.54 | 636.45 | 1.67K | 2.70K | 0.00 | -0.78 | -0.72 | -0.33 | 0.00 | 0.00 | |
Interest Expense | 21.00M | 14.24M | 10.99M | 10.34M | 13.81M | 1.00B | 33.41 | 190.54 | 636.45 | 1.67K | 2.70K | 0.00 | 135.56K | 58.22K | 210.33K | 0.00 | 0.00 | |
Depreciation & Amortization | 21.95M | 22.00M | 21.28M | 19.49M | 23.50M | 615.78K | 15.93M | -363.22 | 1.27K | 3.35K | -49.95K | 0.00 | 980.42K | 17.35K | 30.09K | 43.34K | 8.95K | 189.07 |
EBITDA | -25.06M | -64.65M | -17.04M | -29.62M | -90.84M | -521.40M | -46.28K | -43.94K | -55.82K | -84.04K | -153.15K | -141.59K | 598.18K | -235.74K | -624.09K | -1.61M | -59.01K | -4.54K |
EBITDA Ratio | -15.10% | -2.29% | 11.63% | 16.49% | -45.55% | 8,000.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -247.65% | -12.05% | -31.42% | -92.80% | 0.00% | 0.00% |
Operating Income | -43.15M | -28.72M | 272.00K | 4.50M | -101.67M | 451.92M | -46.28K | -43.42K | -55.19K | -82.36K | -152.72K | -141.59K | -382.24K | -303.30K | -654.84K | -1.66M | -59.01K | -4.54K |
Operating Income Ratio | -26.00% | -16.49% | 0.13% | 2.84% | -66.48% | 7,988.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -247.65% | -19.63% | -32.97% | -95.32% | 0.00% | 0.00% |
Total Other Income/Expenses | -24.00M | -13.60M | -8.80M | -22.55M | -16.13M | -493.78M | 16.34M | -553.76 | 865.32 | 2.06K | 0.00 | 0.00 | 968.99K | -132.33K | -60.55K | -442.87K | 0.00 | 0.00 |
Income Before Tax | -67.16M | -104.46M | -50.15M | -57.15M | -140.03M | -552.07M | -46.25K | -43.97K | -55.19K | -82.36K | -152.72K | -141.59K | 598.18K | -303.30K | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -40.47% | -59.97% | -24.74% | -36.08% | -91.56% | -9,758.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 387.56% | -19.63% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -3.34M | 3.01M | -5.03M | -5.04M | -6.66M | 47.74K | -66.83 | 363.22 | -1.27K | -3.35K | 49.95K | 0.00 | -980.42K | 185.09K | 58.22K | 210.33K | -8.95K | -189.07 |
Net Income | -62.38M | -107.46M | -45.12M | -52.11M | -133.37M | -552.12M | -46.25K | -43.97K | -55.19K | -82.36K | -152.72K | -141.59K | 586.75K | -438.87K | -713.06K | -1.87M | -50.06K | -4.35K |
Net Income Ratio | -37.59% | -61.69% | -22.26% | -32.89% | -87.21% | -9,759.70% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 380.16% | -28.40% | -35.90% | -107.42% | 0.00% | 0.00% |
EPS | -0.16 | -0.29 | -0.12 | -0.14 | -0.37 | -18.36 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | 0.26 | -0.28 | -0.51 | -1.62 | -1.13 | -0.06 |
EPS Diluted | -0.16 | -0.29 | -0.12 | -0.14 | -0.37 | -18.36 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | 0.26 | -0.28 | -0.51 | -1.62 | -1.13 | -0.06 |
Weighted Avg Shares Out | 379.58M | 375.50M | 370.00M | 364.56M | 355.84M | 30.07M | 7.81M | 7.81M | 7.81M | 7.81M | 7.81M | 7.78M | 2.26M | 1.54M | 1.40M | 1.15M | 44.49K | 74.67K |
Weighted Avg Shares Out (Dil) | 379.58M | 375.50M | 370.00M | 364.56M | 355.84M | 30.07M | 7.81M | 7.81M | 7.81M | 7.81M | 7.81M | 7.78M | 2.26M | 1.54M | 1.40M | 1.15M | 44.49K | 74.67K |
TILT Holdings Reports Results of 2024 Annual General Meeting of Shareholders
Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?
TILT Holdings Inc. (TLLTF) Q1 2024 Earnings Call Transcript
TILT Holdings Reports First Quarter 2024 Results
TILT Holdings Secures Funding to Develop Vertical Strategy in Pennsylvania
TILT Sets First Quarter 2024 Conference Call for May 15 at 5:00 p.m. ET
TILT Holdings Crowned a NECANN Cup Winner Third Year in a Row
The Best Marijuana Stocks To Trade In 2024?
TILT Holdings Inc. (TLLTF) Q4 2023 Earnings Call Transcript
TILT Holdings Reports Fourth Quarter and Full Year 2023 Results
Source: https://incomestatements.info
Category: Stock Reports